Generic Pharmaceutical Manufacturer
Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94); P.L. 110 -85 relating to Risk Evaluation and Mitigation Strategy programs.
PHA - Pharmacy
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BROWN RUDNICK LLP
601 13th Street, NW, 6th Floor, Washington, DC, 20005, US
HENRY W MENN (CoS, Sen Bob Graham (01-04)) LISA LAYMAN (SPA, Sen Stabenow (05-07)) CHRISTOPHER BOWLIN (SPA, Sen John McCain (09-13))
CoS, Sen Bob Graham (01-04) SPA, Sen Stabenow (05-07) SPA, Sen John McCain (09-13)